{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:32:23Z","timestamp":1771983143553,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["278998"],"award-info":[{"award-number":["278998"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01195","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T02:00:33Z","timestamp":1445911233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Nordihydroguaiaretic acid enhances the activities of aminoglycosides against methicillin- sensitive and resistant Staphylococcus aureus in vitro and in vivo"],"prefix":"10.3389","volume":"6","author":[{"given":"Edward","family":"Cunningham-Oakes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odel","family":"Soren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getika","family":"Rathor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/AAC.43.2.335","article-title":"Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.","volume":"43","author":"Aeschlimann","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"134","key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2010.00134","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future.","volume":"1","author":"Aminov","year":"2010","journal-title":"Front. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.01231-09","article-title":"Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.","volume":"54","author":"Anantharaman","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","author":"Barry","year":"1999","journal-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/AAC.15.2.152","article-title":"Investigations of the occurrence of gentamicin-resistant Staphylococcus aureus.","volume":"15","author":"Buckwold","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ja.2013.86","article-title":"Antibiotics in the clinical pipeline in 2013.","volume":"66","author":"Butler","year":"2013","journal-title":"J. Antibiot."},{"key":"B8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0732-8893(87)90101-5","article-title":"Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.","volume":"6","author":"Chan","year":"1987","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.12.4.564","article-title":"Plant products as antimicrobial agents.","volume":"12","author":"Cowan","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B10","first-page":"99","article-title":"The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.","volume":"58","author":"Edson","year":"1983","journal-title":"Mayo Clinic proceedings"},{"key":"B11","author":"EUCAST","year":"2013","journal-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters,"},{"key":"B12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/sur.2011.068","article-title":"The changing face of Staphylococcus aureus: a continuing surgical challenge.","volume":"12","author":"Fry","year":"2011","journal-title":"Surg. Infect. (Larchmt)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1128\/AAC.44.6.1716-1719.2000","article-title":"In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.","volume":"44","author":"Giacometti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","first-page":"475","article-title":"Antioxidant and antimicrobial activities, and phenolic compounds of selected Inula species from Turkey.","volume":"8","author":"Gokbulut","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jac\/dks354","article-title":"The emerging problem of linezolid-resistant Staphylococcus.","volume":"68","author":"Gu","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jac\/8.6.429","article-title":"Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells.","volume":"8","author":"Hancock","year":"1981","journal-title":"J. Antimicrob. Chemother."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/AAC.43.7.1693","article-title":"Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems.","volume":"43","author":"Hilliard","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/jac\/dks384","article-title":"Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.","volume":"68","author":"Hu","year":"2012","journal-title":"J. Antimicrobial. Chemother."},{"issue":"e0117664","key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117664","article-title":"Combinations of beta-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus.","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1046\/j.1365-2672.2003.01923.x","article-title":"Membrane damage to bacteria caused by single and combined biocides.","volume":"94","author":"Johnston","year":"2003","journal-title":"J. Appl. Microbiol."},{"issue":"e5","key":"B21","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399410001766","article-title":"Antibiotic adjuvants: multicomponent anti-infective strategies.","volume":"13","author":"Kalan","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/AAC.49.8.3435-3441.2005","article-title":"Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes.","volume":"49","author":"Kugelberg","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0041-0101(02)00203-9","article-title":"Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse.","volume":"40","author":"Lambert","year":"2002","journal-title":"Toxicon"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus.","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B26","article-title":"Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.","volume":"16","author":"Lu","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.2174\/1381612821666150310101851","article-title":"Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections.","volume":"21","author":"Magana","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"R62","key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/cc10036","article-title":"Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study.","volume":"15","author":"Magret","year":"2011","journal-title":"Crit. Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1073\/pnas.79.21.6693","article-title":"Membrane potential and gentamicin uptake in Staphylococcus aureus.","volume":"79","author":"Mates","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neulet.2011.10.060","article-title":"In vitro protection of auditory hair cells by salicylate from the gentamicin-induced but not neomycin-induced cell loss.","volume":"506","author":"Mazurek","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jac\/dkr510","article-title":"Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression.","volume":"67","author":"Mitchell","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them.","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/jac\/dkh114","article-title":"Anti-staphylococcal activity and mode of action of clofazimine.","volume":"53","author":"Oliva","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jac\/dku409","article-title":"Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents.","volume":"70","author":"Ooi","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/jac\/dkp299","article-title":"XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.","volume":"64","author":"Ooi","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/toxsci\/kfq267","article-title":"An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin.","volume":"119","author":"Quiros","year":"2011","journal-title":"Toxicol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-induced ototoxicity.","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt0205-155","article-title":"Antiinfective biotechs face partnering gap.","volume":"23","author":"Sheridan","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","article-title":"Versatility of aminoglycosides and prospects for their future.","volume":"16","author":"Vakulenko","year":"2003","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:38:00Z","timestamp":1567283880000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01195\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01195","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}